In recent years, technological innovations in the field of molecular biology have provided new therapeutic options. In particular, human monoclonal antibodies (mAbs), initially used in the treatment of malignancies, have become a therapeutic tool for many other diseases. Most of the application of mAbs revealed encouraging findings to treat patients with immune-mediated glomerular diseases, for whom the standard protocols based on corticosteroids and non-specific immunosuppressants with heavy side effects have for decades been the only therapies.

Monoclonal antibodies for renal diseases: current concepts and ongoing treatments

Santoro, Domenico
Primo
;
Visconti, Luca;Trifirò, Gianluca;Cernaro, Valeria;Buemi, Michele
Ultimo
2015-01-01

Abstract

In recent years, technological innovations in the field of molecular biology have provided new therapeutic options. In particular, human monoclonal antibodies (mAbs), initially used in the treatment of malignancies, have become a therapeutic tool for many other diseases. Most of the application of mAbs revealed encouraging findings to treat patients with immune-mediated glomerular diseases, for whom the standard protocols based on corticosteroids and non-specific immunosuppressants with heavy side effects have for decades been the only therapies.
2015
File in questo prodotto:
File Dimensione Formato  
2015 Expert Opin Biol Ther -Monoclonal in renal diseases.pdf

solo gestori archivio

Descrizione: Articolo principale - Edizione online
Tipologia: Versione Editoriale (PDF)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 425.75 kB
Formato Adobe PDF
425.75 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Santoro_trifirò_Monoclonal.pdf

solo utenti autorizzati

Descrizione: Articolo principale - Edizione a stampa
Tipologia: Versione Editoriale (PDF)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 8.61 MB
Formato Adobe PDF
8.61 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3061340
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact